Tag
2 articles across Siften
McGill University researchers have identified the molecular switch that activates a secondary heat-producing pathway in brown fat — an enzyme called TNAP triggered by glycerol — in findings published in Nature that open new possibilities for obesity and bone disease treatment.
Around one in eight American adults is now taking a GLP-1 drug like Ozempic, and the cumulative effect on dining, snacking, and grocery shopping is becoming a measurable structural force — with dinner traffic down 6% among regular users and food companies scrambling to adapt their products.